Orlov S. Nicole Schaeffer - 28 May 2024 Form 4 Insider Report for INSMED Inc (INSM)

Signature
/s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact
Issuer symbol
INSM
Transactions as of
28 May 2024
Net transactions value
-$1,016,125
Form type
4
Filing time
30 May 2024, 17:44:10 UTC
Previous filing
15 May 2024
Next filing
05 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $345,950 +27,500 +25% $12.58 136,260 28 May 2024 Direct F1
transaction INSM Common Stock Sale $1,362,075 -27,500 -20% $49.53 108,760 28 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $0 -27,500 -100% $0.000000* 0 28 May 2024 Common Stock 27,500 $12.58 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.